United States · 
Who invested in Immunitas?
Immunitas's investors include Novartis Venture Fund, Bayer, Alexandria Real Estate Equities, M/VENTURES and Evotec. Novartis Venture Fund led its latest round.
United States · Series A startup
Who invested in Immunitas
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$39Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $39MNov 2019
- Led by
- Novartis Venture Fund and Bayer
- Investors
- 5 (2 led)
The rounds
- Nov 2019Series A$39M
Reported by FinSMEs
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immunitas
How much has Immunitas raised?
Immunitas has raised $39M across 1 round since 2019.
When did Immunitas last raise?
Immunitas's most recent round was a Series A of $39M in Nov 2019, led by Novartis Venture Fund.
What was Immunitas's biggest round?
Its most recent round, $39M in Nov 2019, is also its largest on record.
Who backed Immunitas first?
Immunitas's first round on record, in Nov 2019, was backed by Novartis Venture Fund, Bayer and Alexandria Real Estate Equities and 2 others.
What stage is Immunitas at?
Immunitas's latest named round is a Series A, in Nov 2019.
Where is Immunitas based?
Immunitas is based in the United States.
Who led Immunitas's rounds?
Novartis Venture Fund led the Series A in 2019.
Companies like Immunitas
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.